JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 29, 2008; DOI: 10.1124/jpet.108.141788


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.141788v1
327/2/365    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Thomas, R. L
Right arrow Articles by Challiss, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, R. L
Right arrow Articles by Challiss, R. J.


Received for publication June 3, 2008.
Revised July 26, 2008.
Accepted for publication July 28, 2008.

G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists

Rachel L Thomas 1, Rajendra Mistry 1, Christopher J Langmead 2, Martyn D Wood 2, RA John Challiss 1*

1 University of Leicester 2 GlaxoSmithKline

* Address correspondence to: E-mail: jc36{at}leicester.ac.uk

Abstract

The M1 muscarinic acetylcholine (mACh) receptor is among a growing number of G protein-coupled receptors that are able to activate multiple signaling cascades. AC-42 is an allosteric agonist that can selectively activate the M1 mACh receptor in the absence of an orthosteric ligand. Allosteric agonists have the potential to stabilize unique receptor conformations, which may in turn cause differential activation of signal transduction pathways. In the present study we have investigated the signaling pathways activated by AC-42, its analog 77-LH-28-1 and a range of orthosteric muscarinic agonists (oxotremorine-M (oxo-M), arecoline and pilocarpine) in Chinese hamster ovary cells recombinantly expressing the human M1 mACh receptor. Each agonist was able to activate G{alpha}q/11-dependent signaling, as demonstrated by an increase in [35S]-GTP{gamma}S binding to G{alpha}q/11 proteins and total [3H]-inositol phosphate accumulation assays in intact cells. All three orthosteric agonists caused significant enhancements in [35S]-GTP{gamma}S binding to G{alpha}i1/2 subunits over basal, however, neither allosteric ligand produced a significant response. In contrast, both orthosteric and allosteric agonists are able to couple to the G{alpha}s/cyclic AMP pathway enhancing forskolin-stimulated cyclic AMP accumulation. These data provide support for the concept that allosteric and orthosteric mACh receptor agonists both stabilize receptor conformations associated with G{alpha}q/11- and G{alpha}s-dependent signaling, however, AC-42 and 77-LH-28-1, unlike oxo-M, arecoline and pilocarpine, do not appear to promote M1 mACh receptor-G{alpha}i1/2 coupling, suggesting that allosteric agonists have the potential to activate distinct subsets of downstream effectors.


Key words: allosteric agonist, functional selectivity, muscarinic receptor, phosphoinositide turnover, receptor-G protein coupling, signal transduction





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.